查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1703412

急性腦室外引流市場－全球產業規模、佔有率、趨勢、機會和預測（按應用、按患者類型、按地區和競爭細分，2020-2030 年）

Acute External Ventricular Drain Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Patient Type, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球急性腦室外引流市場價值為 2.5234 億美元，預計在預測期內將實現令人印象深刻的成長，到 2030 年的複合年成長率為 5.40%。全球醫療保健產業對神經外科手術和設備的需求一直在穩步成長，而急性腦室外引流 (EVD) 是在顱內疾病患者管理中發揮關鍵作用的關鍵設備之一。 EVD 是監測和管理腦脊髓液 (CSF) 水平、顱內壓 (ICP) 以及協助各種神經外科手術的必不可少的工具。全球急性體外腦室引流市場在過去幾年中經歷了顯著成長，預計將繼續保持上升趨勢。

市場概覽
預測期 2026-2030
2024年市場規模 2.5234億美元
2030年市場規模 3.4677億美元
2025-2030 年複合年成長率 5.40%
成長最快的領域 創傷性腦損傷
最大的市場 北美洲

關鍵市場促進因素

神經系統疾病發生率上升

主要市場挑戰

法規遵從和品質保證

主要市場趨勢

技術進步

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：急性腦室外引流市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依應用（創傷性腦損傷 (TBI)、蜘蛛網膜下腔出血、腦出血、其他）
    • 依患者類型（兒科、成人）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美急性腦室外引流市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲急性腦室外引流市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太急性腦室外引流市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲急性腦室外引流市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲急性腦室外引流市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：全球急性腦室外引流市場：SWOT 分析

第 14 章：競爭格局

  • Medtronic plc
  • Integra LifeSciences Corporation
  • Natus Medical Incorporated
  • Fuji Systems Corporation
  • Spiegelberg GmbH
  • SOPHYSA inc.
  • Neuromedex inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16732

Global Acute External Ventricular Drain Market was valued at USD 252.34 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.40% through 2030. The global healthcare industry has been witnessing a steady rise in the demand for neurosurgical procedures and devices, and one such critical device that plays a pivotal role in the management of patients with intracranial conditions is the Acute External Ventricular Drain (EVD). EVDs are indispensable tools for monitoring and managing cerebrospinal fluid (CSF) levels, intracranial pressure (ICP), and assisting in various neurosurgical procedures. The global Acute External Ventricular Drain market has been experiencing significant growth over the past few years and is expected to continue its upward trajectory.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 252.34 Million
Market Size 2030USD 346.77 Million
CAGR 2025-20305.40%
Fastest Growing SegmentTraumatic Brain Injury
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Neurological Disorders

The Global Acute External Ventricular Drain (EVD) Market has been experiencing steady growth in recent years, driven by a combination of factors that reflect the increasing prevalence of neurological disorders, advancements in medical technology, and a growing aging population. In 2021, over 3 billion individuals globally were affected by neurological conditions, underscoring a significant and growing healthcare challenge. The World Health Organization (WHO) played an active role in interpreting data from the Global Burden of Disease, Injuries, and Risk Factor Study (GBD) 2021, offering critical insights to inform strategic healthcare planning and investment decisions across both public and private sectors. EVD is a crucial medical device used in the management of conditions like hydrocephalus, traumatic brain injuries, and intracranial hemorrhage. In 2019, traumatic brain injury (TBI) accounted for 27.16 million new cases globally, with 48.99 million individuals living with the condition and 7.08 million years lived with disability (YLDs). In parallel, spinal cord injury (SCI) recorded 0.91 million new cases, 20.64 million prevalent cases, and 6.20 million YLDs. One of the primary drivers of the Global Acute EVD Market is the increasing incidence of neurological disorders worldwide. Neurological conditions, such as hydrocephalus, which involves the accumulation of cerebrospinal fluid in the brain, often require surgical intervention, including the use of EVDs. Additionally, traumatic brain injuries and intracranial hemorrhages, which can result from accidents or falls, necessitate immediate medical attention, leading to an increased demand for EVDs.

Key Market Challenges

Regulatory Compliance and Quality Assurance

One of the primary challenges in the EVD market is ensuring compliance with rigorous regulatory requirements and maintaining high-quality standards. These devices are critical for patient safety, and any flaws in design, manufacturing, or usage can have severe consequences. Manufacturers must adhere to strict guidelines set by regulatory bodies like the FDA and CE (Conformite Europeene) in Europe. Ensuring compliance while striving for innovation is a delicate balance that EVD companies must navigate.

Key Market Trends

Technological Advancements

The healthcare industry has witnessed remarkable transformations in recent years, largely driven by technological advancements that have revolutionized patient care, diagnosis, and treatment. One area where these advancements are making a significant impact is in the field of neurosurgery and critical care. The Global Acute External Ventricular Drain (EVD) Market is experiencing substantial growth due to the integration of cutting-edge technologies, making it an integral component of modern medical practice. Recent advancements in material science and engineering have led to the development of smaller, lightweight, and biocompatible EVD devices. Miniaturized EVDs offer several benefits, including reduced infection risk, ease of placement, and patient comfort. Additionally, these devices are less obtrusive, making them more patient-friendly while providing healthcare professionals with enhanced monitoring capabilities.

Wireless technology has brought a new dimension to EVD management. Modern EVD systems are equipped with wireless sensors and connectivity options that allow real-time monitoring and remote data access. This enables healthcare providers to closely monitor patients' ICP and CSF pressure without being physically present, making it especially valuable in telemedicine and remote patient management scenarios. Artificial intelligence (AI) and machine learning algorithms have made significant inroads in healthcare, including the neurosurgical field. AI-powered EVD systems can analyze vast amounts of data, providing insights into trends and patterns in ICP and CSF pressure. This data-driven approach allows for more precise prediction of critical events and timely interventions, potentially saving lives and improving patient outcomes. Infections associated with EVDs have been a long-standing concern. However, technological advancements have led to the development of EVDs with enhanced infection control features. Antimicrobial-coated catheters, closed drainage systems, and sterile insertion techniques have significantly reduced the risk of infections associated with EVD placement, improving patient safety.

Key Market Players

  • Medtronic plc
  • Integra LifeSciences Corporation
  • Natus Medical Incorporated
  • Fuji Systems Corporation
  • Spiegelberg GmbH
  • SOPHYSA inc.
  • Neuromedex inc.

Report Scope:

In this report, the Global Acute External Ventricular Drain Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Acute External Ventricular Drain Market, By Application:

  • Traumatic Brain Injury (TBI)
  • Subarachnoid Hemorrhage
  • Intracerebral Hemorrhage
  • Others

Acute External Ventricular Drain Market, By Patient Type:

  • Pediatric
  • Adult

Acute External Ventricular Drain Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Acute External Ventricular Drain Market.

Available Customizations:

Global Acute External Ventricular Drain market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Acute External Ventricular Drain Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Traumatic Brain Injury (TBI), Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Others)
    • 5.2.2. By Patient Type (Pediatric, Adult)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Acute External Ventricular Drain Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Patient Type
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Acute External Ventricular Drain Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Patient Type
    • 6.3.2. Canada Acute External Ventricular Drain Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Patient Type
    • 6.3.3. Mexico Acute External Ventricular Drain Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Patient Type

7. Europe Acute External Ventricular Drain Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Patient Type
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Acute External Ventricular Drain Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Patient Type
    • 7.3.2. United Kingdom Acute External Ventricular Drain Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Patient Type
    • 7.3.3. Italy Acute External Ventricular Drain Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Patient Type
    • 7.3.4. France Acute External Ventricular Drain Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Patient Type
    • 7.3.5. Spain Acute External Ventricular Drain Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Patient Type

8. Asia-Pacific Acute External Ventricular Drain Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Patient Type
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Acute External Ventricular Drain Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Patient Type
    • 8.3.2. India Acute External Ventricular Drain Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Patient Type
    • 8.3.3. Japan Acute External Ventricular Drain Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Patient Type
    • 8.3.4. South Korea Acute External Ventricular Drain Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Patient Type
    • 8.3.5. Australia Acute External Ventricular Drain Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Patient Type

9. South America Acute External Ventricular Drain Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Patient Type
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Acute External Ventricular Drain Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Patient Type
    • 9.3.2. Argentina Acute External Ventricular Drain Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Patient Type
    • 9.3.3. Colombia Acute External Ventricular Drain Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Patient Type

10. Middle East and Africa Acute External Ventricular Drain Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Patient Type
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Acute External Ventricular Drain Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Patient Type
    • 10.3.2. Saudi Arabia Acute External Ventricular Drain Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Patient Type
    • 10.3.3. UAE Acute External Ventricular Drain Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Patient Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Acute External Ventricular Drain Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Medtronic plc
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Integra LifeSciences Corporation
  • 14.3. Natus Medical Incorporated
  • 14.4. Fuji Systems Corporation
  • 14.5. Spiegelberg GmbH
  • 14.6. SOPHYSA inc.
  • 14.7. Neuromedex inc.

15. Strategic Recommendations

16. About Us & Disclaimer